Atlas Trials

David S Shulman, MD

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch David S Shulman, MD

RecordFirmDate
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas (NCT06709495)David S Shulman, MD2025-01-27

Track David S Shulman, MD automatically

Every clearance here is in the API, with alerts when new ones post.